Nuvalent, Inc.
NUVL · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.57 | -0.77 | -1.21 | 1.04 |
| FCF Yield | -1.13% | -1.40% | -1.08% | -1.11% |
| EV / EBITDA | -54.33 | -51.20 | -52.29 | -62.86 |
| Quality | ||||
| ROIC | -12.67% | -10.85% | -9.22% | -7.95% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 0.58 | 0.77 | 0.65 | 0.83 |
| Growth | ||||
| Revenue 3-Year CAGR | -100.00% | -100.00% | -100.00% | -100.00% |
| Free Cash Flow Growth | 8.01% | -39.72% | 11.58% | -35.32% |
| Safety | ||||
| Net Debt / EBITDA | 1.03 | 1.22 | 1.27 | 1.69 |
| Interest Coverage | -11.05 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 |